2006Chinese Journal of New Drugs and Clinical RemediesRequires access

Pharmacokinetics of ziprasidone tablet in healthy subjects

HE Hai-xia

Open publisher page 0 citations

Abstract

AIM: To study the pharmacokinetics of a single oral dose of ziprasidone in 9 healthy male volunteers. METHODS: A single dose of 20 mg of ziprasidone tablet was administed. The blood samples were taken at 1.0,2.0,3.0,4.0,5.0,6.0,7.0,8.0,9.0,10.0,12.0,14.0 h after oral administration. The concentrations of ziprasidone in serum were determined by HPLC method,the pharmacokinetic parameters were calculated with 3P97 program. RESULTS: The concentration-time curves of ziprasidone fitted to one-comprartment model,with cmax as(176 ± s 86) μg·L-1 ,tmax as(4.3 ± 0.9) h,t1/2ke as (3.1 ± 1.4) h, Cl as (0.033 ± 0.010) L·h-1,AUC0-14 as (705 ± 247) μLg·h·L-1,and AUC0-∝ as (920 ± 283) μg·h·L-1. CONCLUSION: The pharmacokinetic parameters by oral administration ziprasidone 20 rag in 9 healthy male volunteers are similar to report of literature.

About this research paper

What this paper is about

AIM: To study the pharmacokinetics of a single oral dose of ziprasidone in 9 healthy male volunteers. METHODS: A single dose of 20 mg of ziprasidone tablet was administed. The blood samples were taken at 1.0,2.0,3.0,4.0,5.0,6.0,7.0,8.0,9.0,10.0,12.0,14.0 h after oral administration. The concentrations of ziprasidone in serum were determined by HPLC method,the pharmacokinetic parameters were calculated with 3P97 program. RESULTS: The concentration-time curves of ziprasidone fitted to one-comprartment model,with cmax as(176 ± s 86) μg·L-1 ,tmax as(4.3 ± 0.9) h,t1/2ke as (3.1 ± 1.4) h, Cl as (0.033 ± 0.010) L·h-1,AUC0-14 as (705 ± 247) μLg·h·L-1,and AUC0-∝ as (920 ± 283) μg·h·L-1. CONCLUSION: The pharmacokinetic parameters by oral administration ziprasidone 20 rag in 9 healthy male volunteers are similar to report of literature.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

AIM: To study the pharmacokinetics of a single oral dose of ziprasidone in 9 healthy male volunteers. METHODS: A single dose of 20 mg of ziprasidone tablet was administed. The blood samples were taken at 1.0,2.0,3.0,4.0,5.0,6.0,7.0,8.0,9.0,10.0,12.0,14.0 h after oral administration. The concentrations of ziprasidone in serum were determined by HPLC method,the pharmacokinetic parameters were calculated with 3P97 program. RESULTS: The concentration-time curves of ziprasidone fitted to one-comprartment model,with cmax as(176 ± s 86) μg·L-1 ,tmax as(4.3 ± 0.9) h,t1/2ke as (3.1 ± 1.4) h, Cl as (0.033 ± 0.010) L·h-1,AUC0-14 as (705 ± 247) μLg·h·L-1,and AUC0-∝ as (920 ± 283) μg·h·L-1. CONCLUSION: The pharmacokinetic parameters by oral administration ziprasidone 20 rag in 9 healthy male volunteers are similar to report of literature.

Key concepts: Ziprasidone, Pharmacokinetics, Cmax, Pharmacology, Oral administration, Absorption (acoustics), Medicine, Chemistry

Related papers

Back to paper searchBrowse research topicsOriginal source
Pharmacokinetics of ziprasidone tablet in healthy subjects — Research Paper | ScholarLens